NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer

NARecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Intraepithelial NeoplasiaCervical Cancer
Interventions
BIOLOGICAL

NWRD09 administered by intramuscular injection

NWRD09 administered by intramuscular injection according to the study protocol.

Trial Locations (1)

Unknown

RECRUITING

Heze Municipal Hospita, Heze

All Listed Sponsors
lead

Newish Technology (Beijing) Co., Ltd.

INDUSTRY